NSE · MANIPALHOS.NS
Manipal Health Enterprises Limited
₹650.10+₹11.30 (+1.77%)
Manipal Health Enterprises Limited’s quoted price sits in the lower half of its reported 52-week range, 20.17% below the high.
Loading market information…
NSE · KIMS.NS · INR
Stock price, earnings
Quote as of Oct 30, 2026, 04:13 AM UTC. Cached market data; not a live quote.
One-year closing-price history · INR. Historical prices are not a forecast.
Krishna Institute of Medical Sciences Limited’s quoted price sits in the lower half of its reported 52-week range, 18.27% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
BEHIND THE RESULTS
Krishna Institute of Medical Sciences Limited’s next earnings report is currently expected on Nov 4, 2026, with estimated earnings per share of ₹1.99. The reporting date and estimates may change.
Upcoming dates and analyst estimates may change. Fiscal quarters follow Krishna Institute of Medical Sciences Limited’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Krishna Institute of Medical Sciences Limited, known by its brand KIMS Hospitals across India, delivers a broad spectrum of medical and healthcare services. The institution boasts a comprehensive array of specialized fields, including cardiology, dentistry, neurology, oncology, orthopedics, nephrology, reproductive medicine, and robotic surgeries. Additionally, it offers expertise in gastroenterology, hepatology, heart and lung transplantation, general organ transplantation, maternal and pediatric care. Other key areas of focus include emergency and accident services, biochemistry, anesthesiology, bariatric surgery, andrology and infertility treatments, arthroscopy, Alzheimer's care, and dedicated bone and joint centers. Founded in 1973, the company is headquartered in Secunderabad, India.
Latest available per-share figures in INR. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 04:14 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
| ₹8.72B+0.7% vs estimate |
| Q4 2025 | May 12, 2025 | ₹2.30-3.36% vs estimate | ₹7.97B-1.45% vs estimate |
|---|
| Q3 2025 | Feb 6, 2025 | ₹2.20-8.33% vs estimate | ₹7.72B+1.89% vs estimate |
|---|
| Q2 2025 | Nov 9, 2024 | ₹2.68+7.2% vs estimate | ₹7.77B+4.06% vs estimate |
|---|
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
₹650.10+₹11.30 (+1.77%)
Manipal Health Enterprises Limited’s quoted price sits in the lower half of its reported 52-week range, 20.17% below the high.
₹751.15-₹3.75 (-0.5%)
Fortis Healthcare Limited’s quoted price sits in the lower half of its reported 52-week range, 28.97% below the high.
₹1,726.60+₹12.10 (+0.71%)
Narayana Hrudayalaya Limited’s quoted price sits in the lower half of its reported 52-week range, 17.51% below the high.
₹1,301.40+₹1.70 (+0.13%)
Global Health Limited’s quoted price sits in the upper half of its reported 52-week range, 15.71% below the high.
₹928.80+₹5.50 (+0.6%)
Yatharth Hospital & Trauma Care Services Limited’s quoted price sits in the upper half of its reported 52-week range, 21.55% below the high.
₹584.35-₹7.10 (-1.2%)
HealthCare Global Enterprises Limited’s quoted price sits in the lower half of its reported 52-week range, 25.18% below the high.
₹258.60-₹1.50 (-0.58%)
Jupiter Life Line Hospitals Limited’s quoted price sits in the lower half of its reported 52-week range, 23.94% below the high.
₹5,791.00-₹105.00 (-1.78%)
Kovai Medical Center and Hospital Limited’s quoted price sits in the upper half of its reported 52-week range, 10.13% below the high.
